The PHH Tug-of-War: 2025’s Market Gains and Losses Analyzed

Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective.

Park Ha Biological Technology Co Ltd’s market performance has been unstable in recent times.

52-week price history of PHH Stock

Examining the 52-week high and low prices can provide valuable insights into a stock’s current status and future performance. Park Ha Biological Technology Co Ltd’s current trading price is -98.53% away from its 52-week high, while its distance from the 52-week low is -1.61%. The stock’s price range during this time has been between $0.62 and $41.49. The trading volume for the Consumer Defensive sector company’s shares reached about 0.83 million for the day, which was lower than the average daily volume of 1.55 million over the last three months.

Market Capitalization vs. Financial Performance: A Comparative Study

Park Ha Biological Technology Co Ltd (PHH) has experienced a quarterly decline of -95.44% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 16.09M and boasts a workforce of 31 employees.

Combining Moving Average and Trading Volume Data for Better Market Insight

Based on Barchart.com data, the company’s moving average over the 100-day period was 13.1677, with a change in price of -9.1100. Similarly, Park Ha Biological Technology Co Ltd recorded 1,139,312 in trading volume during the last 100 days, posting a change of -93.72%.

PHH’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look

The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for PHH stands at 0.05. Similarly, the long-term debt-to-equity ratio is also 0.03.

PHH Stock Stochastic Average

Today, Park Ha Biological Technology Co Ltd’s raw stochastic average for the past 50 days stands at 0.04%, indicating a decline from the raw stochastic average of the last 20 days, which was 3.37%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 3.53% and 5.65% respectively.

Invest Chronicle
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.